• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素拮抗剂的 N 端单聚乙二醇化:PEG 大小与药效学行为的相关性。

N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behavior.

机构信息

National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.

出版信息

Int J Pharm. 2013 Sep 10;453(2):533-40. doi: 10.1016/j.ijpharm.2013.06.022. Epub 2013 Jun 21.

DOI:10.1016/j.ijpharm.2013.06.022
PMID:23796830
Abstract

Growth hormone antagonist (GHA), an analog of growth hormone (GH), can inhibit GH action and treat acromegaly. However, GHA suffers from a short plasma half-life of 15-20 min that has limited its clinical application. PEGylation, conjugation with polyethylene glycol (PEG), can increase the plasma half-life of GHA. Single PEG attachment (mono-PEGylation) at N-terminus of GHA has the advantages of product homogeneity and minimization of the bioactivity loss. Conjugation of large PEG molecule may increase the plasma half-life but could potentially decrease the bioactivity of GHA, due to the steric shielding effect of PEG. Thus, N-terminal mono-PEGylation of GHA with 20 kDa and 40 kDa PEG were used to look for a balance of the two competing factors. Sedimentation velocity analysis suggested that 40 kDa PEG was more efficient than 20 kDa PEG to elongate the molecular shape of the conjugate. As reflected by marginal suppression of insulin-like growth factor I (IGF-I), GHA conjugated with 40 kDa PEG was statistically indistinguishable from the saline solution that could not inhibit GH action. In contrast, GHA conjugated with 20kDa PEG can apparently inhibit GH action, as reflected by IGF-I suppression of 30-43%. Thus, our work demonstrated the effective therapeutic potency of N-terminally mono-PEGylated GHA.

摘要

生长激素拮抗剂(GHA)是生长激素(GH)的类似物,可抑制 GH 的作用并治疗肢端肥大症。然而,GHA 的血浆半衰期较短,仅为 15-20 分钟,这限制了其临床应用。聚乙二醇化(PEGylation),即与聚乙二醇(PEG)的结合,可以延长 GHA 的血浆半衰期。GHA 的 N 端单 PEG 化(mono-PEGylation)具有产品均一性和最小化生物活性损失的优点。大 PEG 分子的结合可能会增加血浆半衰期,但由于 PEG 的空间位阻效应,可能会降低 GHA 的生物活性。因此,使用 20 kDa 和 40 kDa PEG 对 GHA 的 N 端进行单 PEG 化,以寻找这两个竞争因素之间的平衡。沉降速度分析表明,40 kDa PEG 比 20 kDa PEG 更有效地延长了缀合物的分子形状。如胰岛素样生长因子 I(IGF-I)的边际抑制所反映的那样,与生理盐水相比,与 40 kDa PEG 缀合的 GHA 在统计学上无明显差异,生理盐水不能抑制 GH 的作用。相比之下,与 20 kDa PEG 缀合的 GHA 可以明显抑制 GH 的作用,如 IGF-I 抑制 30-43%所反映的那样。因此,我们的工作证明了 N 端单 PEG 化 GHA 的有效治疗效力。

相似文献

1
N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behavior.生长激素拮抗剂的 N 端单聚乙二醇化:PEG 大小与药效学行为的相关性。
Int J Pharm. 2013 Sep 10;453(2):533-40. doi: 10.1016/j.ijpharm.2013.06.022. Epub 2013 Jun 21.
2
Chemical and enzymatic site specific PEGylation of hGH.人 GH 的化学和酶切位点特异性聚乙二醇化。
Bioconjug Chem. 2013 Mar 20;24(3):456-63. doi: 10.1021/bc300594y. Epub 2013 Mar 4.
3
Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.苯基酰胺连接子改善了N端单聚乙二醇化人生长激素的药代动力学和药效学。
Mol Pharm. 2014 Sep 2;11(9):3080-9. doi: 10.1021/mp500266c. Epub 2014 Aug 21.
4
The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats.聚乙二醇重组人生长激素对垂体切除大鼠生长及糖代谢的影响。
Growth Horm IGF Res. 2012 Feb;22(1):30-5. doi: 10.1016/j.ghir.2011.12.002. Epub 2012 Jan 16.
5
N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone.用伪双功能聚乙二醇-十六烷进行N端修饰显著改善人生长激素的药理学特性。
Mol Pharm. 2015 May 4;12(5):1402-11. doi: 10.1021/mp500680p. Epub 2015 Apr 20.
6
Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).使用在Tyr(1)和Lys(12)处经Fmoc保护的GRF(1-29)衍生物进行位点特异性聚乙二醇化,以高产率制备Lys(21)-胺聚乙二醇化生长激素释放因子(GRF)(1-29)。
Bioconjug Chem. 2007 Mar-Apr;18(2):500-6. doi: 10.1021/bc060173z. Epub 2007 Jan 23.
7
Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.肝素琼脂糖柱上重组人成纤维细胞生长因子 2 的固相 N 端聚乙二醇化。
Bioconjug Chem. 2012 Apr 18;23(4):740-50. doi: 10.1021/bc200550f. Epub 2012 Apr 2.
8
Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.抗肿瘤坏死因子药物聚乙二醇化可溶性肿瘤坏死因子受体I改善佐剂诱导性关节炎大鼠的生长激素/胰岛素样生长因子-I系统
Eur J Pharmacol. 2006 Apr 24;536(1-2):204-10. doi: 10.1016/j.ejphar.2006.02.035. Epub 2006 Mar 2.
9
A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.一种长效、单聚乙二醇化的人生长激素类似物是垂体切除大鼠体重增加和骨骼生长的有效刺激剂。
Endocrinology. 2007 Apr;148(4):1590-7. doi: 10.1210/en.2006-1170. Epub 2007 Jan 18.
10
The conformation of the poly(ethylene glycol) chain in mono-PEGylated lysozyme and mono-PEGylated human growth hormone.单聚乙二醇化溶菌酶和单聚乙二醇化人生长激素中聚乙二醇链的构象。
Bioconjug Chem. 2011 Nov 16;22(11):2317-23. doi: 10.1021/bc2003583. Epub 2011 Oct 6.

引用本文的文献

1
Growth hormone receptor agonists and antagonists: From protein expression and purification to long-acting formulations.生长激素受体激动剂和拮抗剂:从蛋白表达和纯化到长效制剂。
Protein Sci. 2023 Sep;32(9):e4727. doi: 10.1002/pro.4727.
2
Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin.单聚乙二醇化α-1 抗胰蛋白酶的 PEG 长度和 PEG 化位点对其结构、热力学、热和蛋白水解稳定性的影响。
Protein Sci. 2022 Sep;31(9):e4392. doi: 10.1002/pro.4392.
3
Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.
遗传密码扩展通过点击化学实现人生长激素受体拮抗剂的位点特异性聚乙二醇化。
Bioconjug Chem. 2020 Sep 16;31(9):2179-2190. doi: 10.1021/acs.bioconjchem.0c00365. Epub 2020 Sep 2.